2012Plastic & Reconstructive SurgeryRequires access

Variations in Complication Rates for Elective Non-Reconstructive Breast Surgery

Philip J. Hanwright, Geoffrey S. Chow, Colton H. McNichols, Caitlin M. Connor, Karl Y. Bilimoria, John Y. S. Kim

Open publisher page 0 citations

Abstract

INTRODUCTION: As elective non-reconstructive breast surgery increases in popularity, there is greater demand for accurate multi-institutional data on post-operative outcomes. This study utilized a multi-institutional database to compare the 30-day morbidities and reoperation rates among the different types of elective non-reconstructive breast surgery. METHODS: Patients in the National Surgical Quality Improvement Program (NSQIP) database who underwent elective breast surgery between 2006 and 2010 were identified using primary CPT codes. Twenty defined morbidities were compared among mastopexy (CPT 19316), reduction mammaplasty (CPT 19318), and augmentation mammaplasty (CPT 19325) procedures using ANOVA and chi-squared tests for continuous variables and categorical variables, respectively. Logistic regression modeling was employed to identify preoperative risk factors for complications. RESULTS: Of the 4,272 patients identified, 654 underwent mastopexy, 2,779 underwent reduction mammaplasty, and 839 underwent augmentation mammaplasty. Complication rates were low in all cohorts, and patients undergoing augmentation mammaplasty had the lowest overall complication rate compared to mastopexy and reduction mammaplasty (1.43% vs. 2.75% vs. 4.64%). Patients undergoing reduction mammaplasty had a modestly elevated incidence of overall morbidity, superficial surgical site infections (SSI), and wound disruptions (P < 0.05). Moreover, thirty-day reoperation rates for mastopexy, reduction mammaplasty, and augmentation mammaplasty were low (2.60%, 1.94%, and 1.19%), as were the rates of life threatening complications (0.15%, 0.18%, and 0%). Only one death (0.02%) was observed for all 4,272 procedures. CONCLUSION: Elective breast surgery is a safe procedure with an extremely low incidence of life threatening complications and mortality. Comprehensive data collated from the NSQIP initiative adds to the literature of single surgeon or center studies. As such, the findings of this multi-institutional study may help further guide patient education and expectations on potentially deleterious outcomes.

About this research paper

What this paper is about

INTRODUCTION: As elective non-reconstructive breast surgery increases in popularity, there is greater demand for accurate multi-institutional data on post-operative outcomes. This study utilized a multi-institutional database to compare the 30-day morbidities and reoperation rates among the different types of elective non-reconstructive breast surgery. METHODS: Patients in the National Surgical Quality Improvement Program (NSQIP) database who underwent elective breast surgery between 2006 and 2010 were identified using primary CPT codes. Twenty defined morbidities were compared among mastopexy (CPT 19316), reduction mammaplasty (CPT 19318), and augmentation mammaplasty (CPT 19325) procedures using ANOVA and chi-squared tests for continuous variables and categorical variables, respectively. Logistic regression modeling was employed to identify preoperative risk factors for complications. RESULTS: Of the 4,272 patients identified, 654 underwent mastopexy, 2,779 underwent reduction mammaplasty, and 839 underwent augmentation mammaplasty. Complication rates were low in all cohorts, and patients undergoing augmentation mammaplasty had the lowest overall complication rate compared to mastopexy and reduction mammaplasty (1.43% vs. 2.75% vs. 4.64%). Patients undergoing reduction mammaplasty had a modestly elevated incidence of overall morbidity, superficial surgical site infections (SSI), and wound disruptions (P < 0.05). Moreover, thirty-day reoperation rates for mastopexy, reduction mammaplasty, and augmentation mammaplasty were low (2.60%, 1.94%, and 1.19%), as were the rates of life threatening complications (0.15%, 0.18%, and 0%). Only one death (0.02%) was observed for all 4,272 procedures. CONCLUSION: Elective breast surgery is a safe procedure with an extremely low incidence of life threatening complications and mortality. Comprehensive data collated from the NSQIP initiative adds to the literature of single surgeon or center studies. As such, the findings of this multi-institutional study may help further guide patient education and expectations on potentially deleterious outcomes.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

INTRODUCTION: As elective non-reconstructive breast surgery increases in popularity, there is greater demand for accurate multi-institutional data on post-operative outcomes. This study utilized a multi-institutional database to compare the 30-day morbidities and reoperation rates among the different types of elective non-reconstructive breast surgery. METHODS: Patients in the National Surgical Quality Improvement Program (NSQIP) database who underwent elective breast surgery between 2006 and 2010 were identified using primary CPT codes. Twenty defined morbidities were compared among mastopexy (CPT 19316), reduction mammaplasty (CPT 19318), and augmentation mammaplasty (CPT 19325) procedures using ANOVA and chi-squared tests for continuous variables and categorical variables, respectively. Logistic regression modeling was employed to identify preoperative risk factors for complications. RESULTS: Of the 4,272 patients identified, 654 underwent mastopexy, 2,779 underwent reduction mammaplasty, and 839 underwent augmentation mammaplasty. Complication rates were low in all cohorts, and patients undergoing augmentation mammaplasty had the lowest overall complication rate compared to mastopexy and reduction mammaplasty (1.43% vs. 2.75% vs. 4.64%). Patients undergoing reduction mammaplasty had a modestly elevated incidence of overall morbidity, superficial surgical site infections (SSI), and wound disruptions (P < 0.05). Moreover, thirty-day reoperation rates for mastopexy, reduction mammaplasty, and augmentation mammaplasty were low (2.60%, 1.94%, and 1.19%), as were the rates of life threatening complications (0.15%, 0.18%, and 0%). Only one death (0.02%) was observed for all 4,272 procedures. CONCLUSION: Elective breast surgery is a safe procedure with an extremely low incidence of life threatening complications and mortality. Comprehensive data collated from the NSQIP initiative adds to the literature of single surgeon or center studies. As such, the findings of this multi-institutional study may help further guide patient education and expectations on potentially deleterious outcomes.

Key concepts: Medicine, Mastopexy, Mammaplasty, Surgery, Breast surgery, Complication, Incidence (geometry), Breast reduction

Related papers

Back to paper searchBrowse research topicsOriginal source
Variations in Complication Rates for Elective Non-Reconstructive Breast Surgery — Research Paper | ScholarLens